Effects of subtotal fasting on plasmatic coagulation, fibrinolytic status and platelet activation: a controlled pilot study in healthy subjects

Nutr Metab Cardiovasc Dis. 2005 Jun;15(3):212-8. doi: 10.1016/j.numecd.2004.12.003.

Abstract

Background and aim: There is considerable controversy as to whether fasting can be recommended to patients with cardiovascular disease. The objective of this study was to determine whether a well-known method of 1-week subtotal fasting affects hemostasis in healthy subjects.

Methods and results: Analyses were carried out before, four times during and 3 days after fasting in 12 fasting subjects (< 300 kcal/day, only from carbohydrates) (group 1), and 8 control subjects (group 2). Plasmatic coagulation (prothrombin time, partial thromboplastin time, p < or = 0.001) and fibrinolysis (plasminogen, plasmin-antiplasmin-complex, p < 0.05) increased during fasting but remained within the normal limits. While the platelet count was similar in both groups, platelet sensitivity to stimulators was reduced in group 1 (P-selectin and activated GP IIb/IIIa on ADP-stimulated platelets, p < or = 0.01). Furthermore, soluble P-selectin (p < or = 0.01) and C-reactive protein were decreased in comparison to group 2 (p < or = 0.05).

Conclusions: Hemostasis and inflammation parameters during 1-week subtotal fasting do not imply an increase in cardiovascular risk.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Coagulation* / physiology
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / etiology*
  • Fasting / physiology*
  • Female
  • Fibrinolysis* / physiology
  • Flow Cytometry
  • Hemostasis
  • Humans
  • Male
  • Pilot Projects
  • Platelet Activation* / physiology
  • Prothrombin Time
  • Risk Factors